Inhibikase Therapeutics, Inc. logo

Inhibikase Therapeutics, Inc. Employee Directory

Pharmaceutical ManufacturingDelaware, United States11-50 Employees

Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on developing therapies to modify the progression of cardiopulmonary diseases, with a primary program targeting pulmonary arterial hypertension (PAH). Its lead candidate, IKT-001, is a prodrug of imatinib designed for PAH, an orphan indication, building on imatinib’s long-standing clinical use and safety profile. The company has conducted non-human primate safety assessments and a bioequivalence study in healthy volunteers to establish dosing relative to imatinib, and has advanced a Phase 3 trial (IMPROVE-PAH) with initial site activation and pre-screening activities. Inhibikase is headquartered in Wilmington, Delaware, with additional offices in Boston, Massachusetts, and maintains a focused team within the pharmaceutical manufacturing and development space.

Find Inhibikase Therapeutics, Inc. employees' phone numbers or email addresses

Inhibikase Therapeutics, Inc. Global Highlights

Location
Employees

North America
32

Minus sign iconPlus sign icon
  • United States Of America
    31
  • Canada
    1

Europe
2

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    1
  • Netherlands
    1

Oceania
1

Minus sign iconPlus sign icon
  • Australia
    1

South America
1

Minus sign iconPlus sign icon
  • Brazil
    1

Inhibikase Therapeutics, Inc.'s Leadership

  • Stylized image of a person
    M. I.
    Chief Executive Officer
    Phone icon
  • Stylized image of a person
    J. J. K.
    Chief Human Resources Officer
    Phone icon
  • Stylized image of a person
    J. F.
    Chief Financial Officer
    Phone icon
  • Stylized image of a person
    K. W.
    Vice President Finance
    Phone icon
  • Stylized image of a person
    C. M.
    Vice President Of Clinical Operations
    Phone icon
  • Stylized image of a person
    R. A.
    President
    Phone icon
  • Stylized image of a person
    C. C.
    President, Head Of Research And Development, Chief Medical Officer
    Phone icon
  • Stylized image of a person
    S. S.
    Head Of Program Leadership
    Phone icon

Inhibikase Therapeutics, Inc. Employee Metrics

100%
50%
0%
2026
2025
  • Business
  • Entrepreneurship
  • Human Resources
  • Accounting
  • Biotechnology
  • Other
  • Community & Social Services

Contact profiles from Inhibikase Therapeutics, Inc.

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    A. M.
    Chairman
    Phone icon
    United StatesUtah
    Jun 23, 2026
  • Stylized image of a person
    M. I.
    Chief Executive Officer
    Phone icon
    United StatesMassachusetts
    Jun 23, 2026
  • Stylized image of a person
    J. A.
    Owner
    Phone icon
    Oct 17, 2024
  • Stylized image of a person
    J. J. K.
    Chief Human Resources Officer
    Phone icon
    United States
    Jun 23, 2026
  • Stylized image of a person
    J. F.
    Chief Financial Officer
    Phone icon
    Oct 24, 2024
  • Stylized image of a person
    R. A.
    President
    Phone icon
    Oct 23, 2024
  • Stylized image of a person
    M. S.
    Vice President, Cmc Development
    Phone icon
    United StatesNorth Carolina
    Jun 23, 2026
  • Stylized image of a person
    A. W.
    Vice President, Head Of Clinical Development
    Phone icon
    United States
    Jun 23, 2026
  • Stylized image of a person
    K. W.
    Vice President Finance
    Phone icon
    United StatesMassachusetts
    Jun 23, 2026
  • Stylized image of a person
    M. A.
    Vice President, Legal
    Phone icon
    United StatesNew York
    Apr 24, 2026

Frequently Asked Questions

What is Inhibikase Therapeutics, Inc. known for?

Minus sign iconPlus sign icon
Inhibikase Therapeutics, Inc. operates in the Pharmaceutical Manufacturing industry. The company's main headquarters is located in 1000 North West Street Suite 1200 Wilmington, Delaware 19801 United States. Explore Inhibikase Therapeutics, Inc.'s company overview page for more information.

What is Inhibikase Therapeutics, Inc.'s most common email format?

Minus sign iconPlus sign icon
Inhibikase Therapeutics, Inc. employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Inhibikase Therapeutics, Inc. email formats with LeadIQ.

How many employees does Inhibikase Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
Inhibikase Therapeutics, Inc. has approximately 31 employees as of June 2026. These team members are located across 4 continents, including North AmericaEuropeOceania.

Who are Inhibikase Therapeutics, Inc.'s key employees and leadership?

Minus sign iconPlus sign icon

As of June 2026, Inhibikase Therapeutics, Inc.'s key employees include:

  • Chief Executive Officer: M. I.
  • Chief Human Resources Officer: J. J. K.
  • Chief Financial Officer: J. F.
  • Vice President Finance: K. W.
  • Vice President Of Clinical Operations: C. M.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.